{"title":"ROBINS-1:用于评估干预措施非随机研究中偏倚风险的工具。","authors":"Iris Hinneburg","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Compared to randomized controlled trials, non-randomized studies of interventions might be biased in additional domains. As most previous tools for assessing risk of bias are not sufficient, a Cochrane working group has developed a new risk of bias tool called ROBINS-I (Risk of bias in non-randomized studies of interventions).</p>","PeriodicalId":18540,"journal":{"name":"Medizinische Monatsschrift fur Pharmazeuten","volume":"40 4","pages":"175-7"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ROBINS-1: A tool for asssessing risk of bias in non-randomised studies of interventions.\",\"authors\":\"Iris Hinneburg\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Compared to randomized controlled trials, non-randomized studies of interventions might be biased in additional domains. As most previous tools for assessing risk of bias are not sufficient, a Cochrane working group has developed a new risk of bias tool called ROBINS-I (Risk of bias in non-randomized studies of interventions).</p>\",\"PeriodicalId\":18540,\"journal\":{\"name\":\"Medizinische Monatsschrift fur Pharmazeuten\",\"volume\":\"40 4\",\"pages\":\"175-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medizinische Monatsschrift fur Pharmazeuten\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medizinische Monatsschrift fur Pharmazeuten","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
与随机对照试验相比，干预措施的非随机研究可能在其他领域存在偏倚。由于之前大多数评估偏倚风险的工具都不充分，Cochrane工作组开发了一种新的偏倚风险工具ROBINS-I (risk of bias in non-random studies of interventions)。
ROBINS-1: A tool for asssessing risk of bias in non-randomised studies of interventions.
Compared to randomized controlled trials, non-randomized studies of interventions might be biased in additional domains. As most previous tools for assessing risk of bias are not sufficient, a Cochrane working group has developed a new risk of bias tool called ROBINS-I (Risk of bias in non-randomized studies of interventions).
期刊介绍：
•Übersichtsbeiträge zum Beispiel zur Anatomie, Physiologie und Pathophysiologie, zur Pharmakologie einer Substanz- oder Indikationsgruppe, zur Behandlung eines Krankheitsbilds •Fallberichte: der klinisch-pharmazeutische Fall •Pharmakologie aktuell: Neue Therapieprinzipien, neue Wirkungsmechanismen, neue Substanzen werden kurz und verständlich vorgestellt •Ernährungsforum: Fundierte Informationen zur Ernährung und zu Diätformen •Fragen aus der Praxis: Experten beantworten Leseranfragen •Editorial: Kommentare zu pharmazeutischen Themen •Nachrichten aus der medizinischen Forschung mit Neuigkeiten zu Diagnostik und Therapie
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
